Cancer Breakthrough Fund participated in Altis Labs' $25M Series A to scale AI endpoints for oncology clinical trials.
SEP 17, 2026
Altis Labs is on a mission to improve patient outcomes by leveraging AI-powered software to predict drug efficacy from imaging data, specifically CT scans, to accelerate clinical research and development
Altis Labs is on a mission to improve patient outcomes by leveraging AI-powered software to predict drug efficacy from imaging data, specifically CT scans, to accelerate clinical research and development.